what happens when you stop taking glp-1 Researchers find medications safe to continue before surgery in patients with diabetes and obesity What Happens When You Stop

Given the heterogeneity of the included evidencespanning case reports, pharmacovigilance analyses, and observational cohortsthis review is framed primarily as a signal-detection and evidence-mapping exercise rather than a causal-inference analysis

Following backlash for releasing OTC Ozempic, experts weigh in on its safety.

RYGB produces higher early postprandial increases in GLP-1 and glucose than OAGB, demonstrating that procedural differences can influence gut hormone and glucose responses.

The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.

The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).

Their findings suggest that patients may be able to continue taking the medications prior to their surgeries without a high risk of aspiration.As more patients begin taking medications to help manage blood sugar l